Alexandria Real Estate Equities stock (US0152711022): shares firm as investors focus on valuation metrics

Alexandria Real Estate Equities is trading steady on the NYSE while investors reassess the life science REIT’s valuation, yield and recent price recovery after a volatile stretch in U.S. listed real estate.

Alexandria Real Estate Equities shares were recently quoted around the low-50 USD range on the New York Stock Exchange, keeping the U.S. life science-focused REIT in focus for investors watching the recovery in listed property names.

The stock, which trades under the ticker ARE on the NYSE in the United States, has seen renewed interest as real estate securities stabilize following a period of higher interest rates, according to recent trading data reported by MarketBeat on 05/27/2026.

As of: 05/06/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Alexandria Real Estate
• Sector/industry: Listed real estate investment trust (life science-focused)
• Headquarters/country: Pasadena, United States
• Core markets: Major U.S. innovation clusters, including Greater Boston, San Francisco Bay Area and San Diego
• Key revenue drivers: Rental income from life science and technology campuses, development and redevelopment projects, and long-term leases with investment-grade tenants
• Home exchange/listing venue: New York Stock Exchange (ARE)
• Trading currency: USD

Alexandria Real Estate Equities: core business model

Alexandria Real Estate centers its strategy on owning, developing and operating collaborative life science and technology campuses in U.S. innovation hubs, with rent from long-duration leases to biotech, pharmaceutical and research tenants providing the bulk of its revenue.

Valuation metrics and multiples for Alexandria Real Estate Equities

For investors looking at Alexandria Real Estate Equities through a valuation lens, the recent share price around the low-50 USD area on the NYSE provides a reference point against which to compare analyst estimates and targeted fair values.

MarketBeat reported that Alexandria Real Estate Equities closed at USD 52.90 on 05/27/2026, with extended-hours trading at USD 52.96 on the same date, illustrating the current cash equity level against which consensus expectations are measured, according to MarketBeat as of 05/27/2026.

On the same platform, a consensus of 16 Wall Street equity research analysts was cited with an average 12-month price target of USD 51.23 for Alexandria Real Estate Equities, with the highest individual target at USD 70.00 and the lowest at USD 42.00, based on data compiled by MarketBeat as of 05/27/2026.

This implies that, relative to the closing price of USD 52.90 on 05/27/2026, the average target of USD 51.23 reflects a modest forecast downside in the low single-digit percentage range over a 12-month horizon, underlining that the stock is broadly viewed as fairly valued by that analyst sample.

Because Alexandria Real Estate Equities is a REIT, many investors also look at income characteristics; Benzinga noted that the stock offered a dividend yield of around 5.07 percent in commentary published on 05/30/2026, highlighting its income profile relative to broader U.S. equities, according to Benzinga as of 05/30/2026.

In the context of other U.S.-listed REITs, a yield in the low- to mid-single-digit range places Alexandria Real Estate Equities among income-generating securities, while its focus on life science campuses differentiates its underlying asset base from more cyclical retail or office property portfolios, as described in company materials dated 02/26/2026.

Investors on German trading venues frequently access Alexandria Real Estate Equities via the Tradegate platform in euros, where the stock typically tracks the primary NYSE quotation adjusted for EUR/USD moves; this offers a bridge for euro-based retail investors who follow U.S. listed REITs.

Conclusion

Alexandria Real Estate Equities remains an actively traded U.S. life science REIT on the NYSE, with its share price in the low-50 USD range as of late May 2026 providing a concrete anchor for current market valuation.

Consensus analyst data compiled by MarketBeat on 05/27/2026 points to an average 12-month target of USD 51.23, slightly below the late-May close, while commentary from Benzinga on 05/30/2026 emphasizes a dividend yield in the area of 5 percent that appeals to income-focused investors.

Against this backdrop, market participants weighing Alexandria Real Estate Equities are likely to focus on how its specialized life science portfolio, income characteristics and interest-rate environment interact to shape future total-return potential, without this constituting a recommendation.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.